Edward J. P. Cartwright

Edward J. P. Cartwright

Auto-generated profile, based on publicly available information

Edward J. P. Cartwright

Department of Medicine, University of Cambridge, Cambridge, UK Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
CKClaudio U. Köser
Claudio U. Köser
MHMatthew T.G. Holden
Matthew T.G. Holden
MEMatthew J. Ellington
Matthew J. Ellington
ECEdward J.P. Cartwright
Edward J.P. Cartwright
NBNicholas M. Brown
Nicholas M. Brown
SPSharon J. Peacock
Sharon J. Peacock
Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial “resistome” of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a “toxome” consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.)

1 February 2013 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
SHSimon R Harris
Simon R Harris
ECEdward Jp Cartwright
Edward Jp Cartwright
MTM Estée Török
M Estée Török
MHMatthew Tg Holden
Matthew Tg Holden
NBNicholas M Brown
Nicholas M Brown
SPSharon J Peacock
Sharon J Peacock
The emergence of meticillin-resistant Staphylococcus aureus (MRSA) that can persist in the community and replace existing hospital-adapted lineages of MRSA means that it is necessary to understand transmission dynamics in terms of hospitals and the community as one entity. We assessed the use of whole-genome sequencing to enhance detection of MRSA transmission between these settings. We studied a putative MRSA outbreak on a special care baby unit (SCBU) at a National Health Service Foundation Trust in Cambridge, UK. We used whole-genome sequencing to validate and expand findings from an infection-control team who assessed the outbreak through conventional analysis of epidemiological data and antibiogram profiles. We sequenced isolates from all colonised patients in the SCBU, and sequenced MRSA isolates from patients in the hospital or community with the same antibiotic susceptibility profile as the outbreak strain. The hospital infection-control team identified 12 infants colonised with MRSA in a 6 month period in 2011, who were suspected of being linked, but a persistent outbreak could not be confirmed with conventional methods. With whole-genome sequencing, we identified 26 related cases of MRSA carriage, and showed transmission occurred within the SCBU, between mothers on a postnatal ward, and in the community. The outbreak MRSA type was a new sequence type (ST) 2371, which is closely related to ST22, but contains genes encoding Panton-Valentine leucocidin. Whole-genome sequencing data were used to propose and confirm that MRSA carriage by a staff member had allowed the outbreak to persist during periods without known infection on the SCBU and after a deep clean. Whole-genome sequencing holds great promise for rapid, accurate, and comprehensive identification of bacterial transmission pathways in hospital and community settings, with concomitant reductions in infections, morbidity, and costs. UK Clinical Research Collaboration Translational Infection Research Initiative, Wellcome Trust, Health Protection Agency, and the National Institute for Health Research Cambridge Biomedical Research Centre.

2 August 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CKClaudio U Köser
Claudio U Köser
MEMatthew J Ellington
Matthew J Ellington
ECEdward J P Cartwright
Edward J P Cartwright
SGStephen H Gillespie
Stephen H Gillespie
NBNicholas M Brown
Nicholas M Brown
SPSharon J Peacock
Sharon J Peacock
This work is partly supported by funding from the Medical Research Council, the European Developing Country Clinical Trials Partnership, the Global Alliance for TB Drug Development, and the European Union.Whole genome sequencing (WGS) promises to be transformative for the practice of clinical microbiology, and the rapidly falling cost and turnaround time mean that this will become a viable technology in diagnostic and reference laboratories in the near future. The objective of this article is to consider at a very practical level where, in the context of a modern diagnostic microbiology laboratory, WGS might be cost-effective compared to current alternatives. We propose that molecular epidemiology performed for surveillance and outbreak investigation and genotypic antimicrobial susceptibility testing for microbes that are difficult to grow represent the most immediate areas for application of WGS, and discuss the technical and infrastructure requirements for this to be implemented.Publisher PDFPeer reviewe

12 August 2013 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
SRSandra Reuter
Sandra Reuter
MEMatthew J. Ellington
Matthew J. Ellington
ECEdward J. P. Cartwright
Edward J. P. Cartwright
CKClaudio U. Köser
Claudio U. Köser
MTM. Estée Török
M. Estée Török
SPSharon J. Peacock
Sharon J. Peacock
Antimicrobial resistance poses a grave threat to human health.1 Efforts to control the emergence and spread of drug-resistant organisms depend on rapid detection and effective treatment of cases combined with epidemiologic investigations and public health interventions to prevent ongoing transmission. Laboratory support for these activities begins with the detection, identification, and antimicrobial susceptibility testing of a pathogen, which are usually performed in a local diagnostic microbiology laboratory. For a minority of organisms, further identification, extended antimicrobial susceptibility testing, and/or confirmation of resistance mechanisms is required, which are commonly performed by reference laboratories. Such laboratories also perform molecular typing to assist epidemiologic investigations and public health surveillance, although current typing methods often lack sufficient resolution to allow accurate inferences regarding transmission events.2-11 Ideally, surveillance should be a dynamic process in which the flow of relevant information is monitored for a range of purposes, including the emergence of clinically significant drug resistance and detection of outbreaks.8 Currently, this information is gathered retrospectively, usually in response to an outbreak, and can fail to have an impact on disease control, as demonstrated by the recent Escherichia coli O104:H4 outbreak in Germany.12

1 August 2013 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
ECEdward J. P. Cartwright
Edward J. P. Cartwright
GPGavin Paterson
Gavin Paterson
KRKathy E. Raven
Kathy E. Raven
EHEwan M. Harrison
Ewan M. Harrison
TGTheodore Gouliouris
Theodore Gouliouris
MTM. Estée Török
M. Estée Török
The emergence of mecC methicillin-resistant Staphylococcus aureus (MRSA) poses a diagnostic challenge for clinical microbiology laboratories. Using the Vitek 2 system, we tested a panel of 896 Staphylococcus aureus isolates and found that an oxacillin-sensitive/cefoxitin-resistant profile had a sensitivity of 88.7% and a specificity of 99.5% for the identification of mecC MRSA isolates. The presence of the mecC gene, determined by bacterial whole-genome sequencing, was used as the gold standard. This profile could provide a zero-cost screening method for identification of mecC -positive MRSA strains.

9 July 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
SHSimon R Harris
Simon R Harris
MTM E Török
M E Török
ECEdward J P Cartwright
Edward J P Cartwright
MQMichael A Quail
Michael A Quail
SPSharon J Peacock
Sharon J Peacock
JPJulian Parkhill
Julian Parkhill